Drug Type Herbal medicine |
Synonyms NOB, nobiletin, 川陈皮素 |
Target |
Action inhibitors |
Mechanism PDE4B inhibitors(Phosphodiesterase 4B inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H24O8 |
InChIKeyLTRBUBSPQISFFL-UHFFFAOYSA-N |
CAS Registry67549-69-3 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | IND Application | China | 14 Sep 2006 | |
| Arthritis, Gouty | Preclinical | China | 01 Aug 2025 | |
| Pulmonary Arterial Hypertension | Preclinical | China | 29 Jun 2025 | |
| Parkinson Disease | Preclinical | Egypt | 25 Jun 2025 | |
| Myocardial Infarction | Preclinical | United States | 23 Apr 2025 | |
| Asthma | Preclinical | China | 27 Sep 2024 |





